226 related articles for article (PubMed ID: 2147047)
21. Growth factor production and requirements during the proliferative response of human T lymphocytes to anti-CD3 monoclonal antibody.
Granelli-Piperno A; Keane M; Steinman RM
J Immunol; 1989 Jun; 142(12):4138-43. PubMed ID: 2524526
[TBL] [Abstract][Full Text] [Related]
22. Cellular interactions in effector cell generation and tumor regression mediated by anti-CD3/interleukin 2-activated tumor-draining lymph node cells.
Yoshizawa H; Chang AE; Shu SY
Cancer Res; 1992 Mar; 52(5):1129-36. PubMed ID: 1531321
[TBL] [Abstract][Full Text] [Related]
23. HLA typing using IL-2 activated T lymphocytes: usefulness in pediatric candidates for allogeneic bone marrow transplantation.
Kubo K; Tachino J; Ichikawa S; Hamamoto K; Ueda K
Bone Marrow Transplant; 1991 Sep; 8(3):185-90. PubMed ID: 1720338
[TBL] [Abstract][Full Text] [Related]
24. The effect of the CD28 activation pathway on the immunosuppressive action of cyclosporine.
Hess AD; Bright EC
Transplantation; 1991 Jun; 51(6):1232-40. PubMed ID: 1646506
[TBL] [Abstract][Full Text] [Related]
25. Role of interleukin 2 receptor beta chain in initiating anti-CD3 and interleukin 2-induced proliferation of human resting T cells.
Moiré N; Calvo CF; Métivier D; Perrot JY; Vaquero C; Hatakeyama M; Senik A
Eur J Immunol; 1990 Sep; 20(9):1981-7. PubMed ID: 2145171
[TBL] [Abstract][Full Text] [Related]
26. Generation propagation, and targeting of human CD4+ helper/killer T cells induced by anti-CD3 monoclonal antibody plus recombinant IL-2. An efficient strategy for adoptive tumor immunotherapy.
Nishimura T; Nakamura Y; Takeuchi Y; Tokuda Y; Iwasawa M; Kawasaki A; Okumura K; Habu S
J Immunol; 1992 Jan; 148(1):285-91. PubMed ID: 1345787
[TBL] [Abstract][Full Text] [Related]
27. Defective thymic T cell activation by concanavalin A and anti-CD3 in autoimmune nonobese diabetic mice. Evidence for thymic T cell anergy that correlates with the onset of insulitis.
Zipris D; Lazarus AH; Crow AR; Hadzija M; Delovitch TL
J Immunol; 1991 Jun; 146(11):3763-71. PubMed ID: 1827815
[TBL] [Abstract][Full Text] [Related]
28. T-cell activation by recombinant receptors: CD28 costimulation is required for interleukin 2 secretion and receptor-mediated T-cell proliferation but does not affect receptor-mediated target cell lysis.
Hombach A; Sent D; Schneider C; Heuser C; Koch D; Pohl C; Seliger B; Abken H
Cancer Res; 2001 Mar; 61(5):1976-82. PubMed ID: 11280755
[TBL] [Abstract][Full Text] [Related]
29. Anti-CD3 monoclonal antibody-mediated cytotoxicity occurs through an interleukin-2-independent pathway in CD3+ large granular lymphocytes.
Loughran TP; Aprile JA; Ruscetti FW
Blood; 1990 Feb; 75(4):935-40. PubMed ID: 2302461
[TBL] [Abstract][Full Text] [Related]
30. Role of CD2 in regulation of CD3- LGL function.
Mason A; Bernard A; Smyth MJ; Ortaldo JR
Eur Cytokine Netw; 1991; 2(1):31-7. PubMed ID: 1714784
[TBL] [Abstract][Full Text] [Related]
31. Role of LFA-1/ICAM-1 in interleukin-2-stimulated lymphocyte proliferation.
Vyth-Dreese FA; Dellemijn TA; Frijhoff A; van Kooyk Y; Figdor CG
Eur J Immunol; 1993 Dec; 23(12):3292-9. PubMed ID: 7903074
[TBL] [Abstract][Full Text] [Related]
32. In vitro responsiveness to interleukins and theophylline of CD16+, CD56- natural killer cells in a patient with chronic granular lymphocyte disorder.
Bayle C; Vitté-Mony I; Lang P; Pico J; Hercend T; Bertoglio J
Leukemia; 1992 May; 6(5):470-6. PubMed ID: 1375700
[TBL] [Abstract][Full Text] [Related]
33. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.
Woods M; Guy R; Waldmann H; Glennie M; Alexander DR
Cell Immunol; 1998 May; 185(2):101-13. PubMed ID: 9636688
[TBL] [Abstract][Full Text] [Related]
34. Blockade of physiologically secreted IFN-gamma inhibits human T lymphocyte and natural killer cell activation.
Novelli F; Giovarelli M; Reber-Liske R; Virgallita G; Garotta G; Forni G
J Immunol; 1991 Aug; 147(4):1445-52. PubMed ID: 1831225
[TBL] [Abstract][Full Text] [Related]
35. Induction of NK activity in large granular lymphocyte leukemia: activation with anti-CD3 monoclonal antibody and interleukin 2.
Loughran TP; Draves KE; Starkebaum G; Kidd P; Clark EA
Blood; 1987 Jan; 69(1):72-8. PubMed ID: 3098327
[TBL] [Abstract][Full Text] [Related]
36. T-cell activation. I. Evidence for a functional linkage between class I MHC antigens and the Tc-Ti complex.
Brams P; Claesson MH
Immunology; 1989 Mar; 66(3):348-53. PubMed ID: 2522906
[TBL] [Abstract][Full Text] [Related]
37. Activation of cord T lymphocytes. III. Role of LFA-1/ICAM-1 and CD2/LFA-3 adhesion molecules in CD3-induced proliferative response.
Gerli R; Agea E; Muscat C; Tognellini R; Fiorucci G; Spinozzi F; Cernetti C; Bertotto A
Cell Immunol; 1993 Apr; 148(1):32-47. PubMed ID: 7684326
[TBL] [Abstract][Full Text] [Related]
38. IL-2 and IL-6 synergize to augment the pore-forming protein gene expression and cytotoxic potential of human peripheral blood T cells.
Smyth MJ; Ortaldo JR; Bere W; Yagita H; Okumura K; Young HA
J Immunol; 1990 Aug; 145(4):1159-66. PubMed ID: 2143209
[TBL] [Abstract][Full Text] [Related]
39. Induction of NK-like activity in T cells by IL-2/anti-CD3 is linked to expression of a new antitumour receptor with specificity for acetylated mannose.
Zollner TM; Zhu HG; Anderer FA
Anticancer Res; 1993; 13(4):923-30. PubMed ID: 8352560
[TBL] [Abstract][Full Text] [Related]
40. Restoration of cytotoxic T lymphocyte function in malignant pleural effusion: interleukin-15 vs. interleukin-2.
Chen YM; Ting CC; Peng JW; Yang WK; Yang KY; Tsai CM; Perng RP
J Interferon Cytokine Res; 2000 Jan; 20(1):31-9. PubMed ID: 10670650
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
